| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.
TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 828.0K | $75.57M | - | |
| Dir | 95.3K | $7.47M | - | |
| COO | 78.5K | $6.68M | - | |
| Other | 64.0K | $4.29M | - | |
| Other | 61.5K | $4.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 15,565 | $80.67 | $1,255,683.96 | -40.0% | -13.1% | - | |
| Dec 24, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $82.51 | $495,089.41 | -0.7% | -23.5% | - | |
| Dec 16, 2025 | Whitfield Dianne C. | Chief Human Resources Officer | Sell | 7,397 | $80.10 | $592,499.70 | -16.0% | -12.0% | - | |
| Dec 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Sale+OE | 2,078 | $79.50 | $165,201.00 | -8.7% | -12.0% | - | |
| Dec 15, 2025 | Link William J Phd | Director | Sell | 22,946 | $81.26 | $1,864,677.82 | -100% | -14.4% | - | |
| Sep 24, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $55.37 | $332,220.00 | -0.7% | +48.6% | - | |
| Sep 8, 2025 | Link William J Phd | Director | Sell | 27,116 | $57.00 | $1,545,612.00 | -15.9% | +44.5% | - | |
| Aug 11, 2025 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 6,000 | $50.00 | $300,000.00 | -0.7% | +45.4% | - | |
| Jun 17, 2025 | Farrow Jeffrey S | See Remarks | Sale+OE | 13,608 | $40.42 | $550,035.36 | -27.0% | +25.8% | +57.2% | |
| Jun 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Sale+OE | 1,006 | $41.08 | $41,326.48 | -11.6% | +20.1% | +50.0% |